Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Am J Hematol. 2010 Jan;85(1):29-35. doi: 10.1002/ajh.21572.
We conducted a genome-wide association study (GWAS) to discover single nucleotide polymorphisms (SNPs) associated with the severity of sickle cell anemia in 1,265 patients with either "severe" or "mild" disease based on a network model of disease severity. We analyzed data using single SNP analysis and a novel SNP set enrichment analysis (SSEA) developed to discover clusters of associated SNPs. Single SNP analysis discovered 40 SNPs that were strongly associated with sickle cell severity (odds for association >1,000); of the 32 that we could analyze in an independent set of 163 patients, five replicated, eight showed consistent effects although failed to reach statistical significance, whereas 19 did not show any convincing association. Among the replicated associations are SNPs in KCNK6 a K(+) channel gene. SSEA identified 27 genes with a strong enrichment of significant SNPs (P < 10(-6)); 20 were replicated with varying degrees of confidence. Among the novel findings identified by SSEA is the telomere length regulator gene TNKS. These studies are the first to use GWAS to understand the genetic diversity that accounts the phenotypic heterogeneity sickle cell anemia as estimated by an integrated model of severity. Additional validation, resequencing, and functional studies to understand the biology and reveal mechanisms by which candidate genes might have their effects are the future goals of this work.
我们进行了一项全基因组关联研究(GWAS),以发现与基于疾病严重程度网络模型的 1265 名“严重”或“轻度”疾病患者的镰状细胞贫血严重程度相关的单核苷酸多态性(SNP)。我们使用单 SNP 分析和一种新的 SNP 集富集分析(SSEA)进行数据分析,该分析方法用于发现相关 SNP 的聚类。单 SNP 分析发现了 40 个与镰状细胞严重程度强烈相关的 SNP(关联的可能性>1000);在我们能够在 163 名患者的独立组中分析的 32 个 SNP 中,有 5 个得到了复制,8 个显示出一致的效果,但未达到统计学意义,而 19 个没有显示出任何令人信服的关联。在复制的关联中,有 K(+)通道基因 KCNK6 的 SNP。SSEA 确定了 27 个具有强烈显著 SNP 富集的基因(P<10(-6));其中 20 个具有不同程度的置信度得到了复制。SSEA 鉴定出的新发现之一是端粒长度调节基因 TNKS。这些研究首次使用 GWAS 来理解遗传多样性,这种遗传多样性是通过严重程度的综合模型来估计的,该模型解释了镰状细胞贫血的表型异质性。未来的目标是进一步验证、重测序和功能研究,以了解候选基因的生物学,并揭示其作用机制。